Back to Journals » Vascular Health and Risk Management » Volume 8

Predictors of poor blood pressure control assessed by 24 hour monitoring in patients with type B acute aortic dissection

Authors Delsart P, Midulla M, Sobocinski J, Achere C, Haulon S, Claisse G, Mounier-Vehier C

Received 22 July 2011

Accepted for publication 16 November 2011

Published 10 January 2012 Volume 2012:8 Pages 23—30


Review by Single-blind

Peer reviewer comments 3

Pascal Delsart1, Marco Midulla2, Jonathan Sobocinski3, Charles Achere4, Stephan Haulon3, Gonzague Claisse1, Claire Mounier-Vehier1
Vascular Medicine and Hypertension Department, Cardiology Hospital, CHRU Lille, 2Radiology and Cardiovascular Imaging Department, Cardiology Hospital, CHRU Lille, 3Vascular Surgery Department, Cardiology Hospital, CHRU Lille, 4Cardiology Department, Cardiology Hospital, CHRU Lille, France

Abstract: The chronic management of post-acute aortic dissection (AD) of the descending aorta (Type B) is based on optimal control of blood pressure (BP), with a target BP < 135/80 mmHg. The aim of our study was to determine and verify effective blood pressure control with an objective measurement method and to identify predicting factors.
Methods: We collected data from 26 patients hospitalized in the acute phase of a Type B AD between 2006 and 2009. Two groups were defined according to 24 hour BP monitoring results at follow-up. Group 1 consisted of patients with a controlled BP (< 130/80 mmHg), and Group 2 consisted of patients with an uncontrolled BP.
Results: Thirty four percent of patients showed an uncontrolled BP at checkup. Vascular history before AD (P = 0.06), high baseline BP trend (P = 0.01 for systolic and P = 0.08 for diastolic), and greater diameter of the descending aorta (P = 0.02) were associated with poor BP control.
Conclusion: Prognosis after AD is associated with BP control. Therefore, 24 hour BP monitoring can be made.

Keywords: acute aortic syndrome, blood pressure monitoring, hypertension

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]


Other article by this author:

Should we screen for masked hypertension in patient with vascular disease?

Pascal Delsart, Philippe Marboeuf, Cedric Delhaye, et al

Vascular Health and Risk Management 2010, 6:333-338

Published Date: 10 May 2010

Readers of this article also read:

One-year monitoring of an oligonucleotide fluorescence in situ hybridization probe panel laboratory-developed test for bladder cancer detection

Tinawi-Aljundi R, King L, Knuth ST, Gildea M, Ng C, Kahl J, Dion J, Young C, Schervish EW, Frontera JR, Hafron J, Kernen KM, Di Loreto R, Aurich-Costa J

Research and Reports in Urology 2015, 7:49-55

Published Date: 9 April 2015

Validation of the custo screen 400 ambulatory blood pressure-monitoring device according to the European Society of Hypertension International Protocol revision 2010

Bramlage P, Deutsch C, Krüger R, Wolf A, Müller P, Zwingers T, Beime B, Mengden T

Vascular Health and Risk Management 2014, 10:303-309

Published Date: 13 May 2014

The 24-hour pulse wave velocity, aortic augmentation index, and central blood pressure in normotensive volunteers

Kuznetsova TY, Korneva VA, Bryantseva EN, Barkan VS, Orlov AV, Posokhov IN, Rogoza AN

Vascular Health and Risk Management 2014, 10:247-251

Published Date: 28 April 2014

The use of telephone monitoring for diabetic patients: theory and practical implications

Koutsouris D, Lazakidou A, Vellidou E, Iliopoulou D, Petridou M, Koutsouri G, Giokas K, Fotiadis D

Smart Homecare Technology and TeleHealth 2014, 2:13-17

Published Date: 17 March 2014

Antihypertensive therapy: nocturnal dippers and nondippers. Do we treat them differently?

Mahabala C, Kamath P, Bhaskaran U, Pai ND, Pai AU

Vascular Health and Risk Management 2013, 9:125-133

Published Date: 24 March 2013